Dr. Mahler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
# Mskcc
New York, NY 10065Phone+1 212-639-5966Fax+1 212-717-3447
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2007 - 2011
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2003 - 2006
- University of the WitwatersrandClass of 2000
Certifications & Licensure
- NY State Medical License 2006 - 2018
Publications & Presentations
PubMed
- 323 citationsIbrutinib Combined With Bendamustine and Rituximab Compared With Placebo, Bendamustine, and Rituximab for Previously Treated Chronic Lymphocytic Leukaemia or Small Lym...Asher Chanan-Khan, Paula Cramer, Fatih Demirkan, Graeme Fraser, Rodrigo Santucci Silva
The Lancet. Oncology. 2016-02-01 - 25 citationsSafety and Immunogenicity of the Tetravalent Protein-Conjugated Meningococcal Vaccine (MCV4) in Recipients of Related and Unrelated Allogeneic Hematopoietic Stem Cell ...Michelle Mahler, Ying Taur, Raymond Jean, Nancy A. Kernan, Susan E. Prockop
Biology of Blood and Marrow Transplantation. 2012-01-01 - 2 citationsSystemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS TrialSilvia Maria Lavezzi, Jan de Jong, Martine Neyens, Paula Cramer, Fatih Demirkan
Pharmaceutical Research. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: